ArticleBritish journal of pharmacology2012

A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.

G M Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.